Palisade Bio (PALI) Revenue (2011 - 2023)
Palisade Bio's (PALI) quarterly Revenue came in at $250000.0 in Q1 2023, up 9900.0% on a QoQ basis from $2500.0 in Q4 2020.
Palisade Bio (PALI) Revenue (2011 - 2023) Analysis & Trends
Palisade Bio (PALI) has 11 years of Revenue data on file, last reported at $250000.0 in Q1 2023.
- On a quarterly basis, Revenue changed N/A year-over-year to $250000.0 in Q1 2023; TTM through Dec 2023 was $250000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $250000.0, changed N/A from the prior year.
- Revenue for Q1 2023 stood at $250000.0, up from $2500.0 in the prior quarter.
- Over the last five years, Revenue for PALI reached as high as $250000.0 in Q1 2023 and fell as low as $2500.0 in Q1 2019.
- Historically, Revenue has averaged $30990.4 across 3 years, with a median of $2500.0 in 2019.
- Across the five-year window, Revenue sank 96.87% in 2019 and surged 140.8% in 2020, its largest moves.
- Year by year, Revenue stood at $2500.0 in 2019, then changed by 0.0% to $2500.0 in 2020, then surged by 9900.0% to $250000.0 in 2023.
- Per Business Quant data, the three most recent Revenue figures were $250000.0 in Q1 2023, $2500.0 in Q4 2020, and $2500.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Palisade Bio | 413.04 Mn | 280.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2020 | 2,500.00 |
| Sep 30, 2020 | 2,500.00 |
| Jun 30, 2020 | 2,500.00 |
| Mar 31, 2020 | 6,020.00 |
| Dec 31, 2019 | 2,500.00 |
| Sep 30, 2019 | 2,500.00 |
| Jun 30, 2019 | 7,894.00 |
| Mar 31, 2019 | 2,500.00 |
| Dec 31, 2018 | 2,500.00 |
| Sep 30, 2018 | 2,500.00 |
| Jun 30, 2018 | 252,500.00 |
| Mar 31, 2018 | 2,500.00 |
| Dec 31, 2017 | 252,500.00 |
| Sep 30, 2017 | 2,500.00 |
| Jun 30, 2017 | 2,500.00 |
| Mar 31, 2017 | 2,500.00 |
| Dec 31, 2016 | 8,746.00 |
| Sep 30, 2016 | 2,500.00 |
| Jun 30, 2016 | 2,500.00 |